GLP-1 secretion is regulated by IL-6 signalling: a randomised, placebo-controlled study https://t.co/uLEWLmxcTV
IL-6 is implicated in the regulation of GLP-1 in humans https://t.co/k9eNIxeu0I
IL-6 receptor blockade lowered active GLP-1 levels in humans #USBEndo @CFAS_dk @UniSpitalBasel https://t.co/IIIWVQQxpt https://t.co/DAoScHZ6kj
GLP-1 secretion is regulated by IL-6 signalling: a randomised, placebo-controlled study https://t.co/exZh4ba9tv #obesity #diabetes #MetbolicSyndrome #InsulinResistance
If you guys have access and can't wait to read it, the paper can be found here https://t.co/pvf0y7iGXP
RT @DanielJDrucker: More evidence for the IL-6 GLP-1 axis in humans @DiabetologiaJnl https://t.co/BKjjXDS1qz
RT @DanielJDrucker: More evidence for the IL-6 GLP-1 axis in humans @DiabetologiaJnl https://t.co/BKjjXDS1qz
RT @DanielJDrucker: More evidence for the IL-6 GLP-1 axis in humans @DiabetologiaJnl https://t.co/BKjjXDS1qz
RT @DanielJDrucker: More evidence for the IL-6 GLP-1 axis in humans @DiabetologiaJnl https://t.co/BKjjXDS1qz
RT @YukiUehara7: 【GLP1・IL-6】GLP-1分泌はIL-6シグナルにより制御される 2型糖尿病または肥満患者を対象に、運動中のGLP1レベルに対するトシリズマブ(IL-6受容体拮抗薬)およびシタグリプチン(DPP4阻害剤)の作用を検証 トシリズマブによ…
RT @YukiUehara7: 【GLP1・IL-6】GLP-1分泌はIL-6シグナルにより制御される 2型糖尿病または肥満患者を対象に、運動中のGLP1レベルに対するトシリズマブ(IL-6受容体拮抗薬)およびシタグリプチン(DPP4阻害剤)の作用を検証 トシリズマブによ…
【GLP1・IL-6】GLP-1分泌はIL-6シグナルにより制御される 2型糖尿病または肥満患者を対象に、運動中のGLP1レベルに対するトシリズマブ(IL-6受容体拮抗薬)およびシタグリプチン(DPP4阻害剤)の作用を検証 トシリズマブによりGLP1レベルは低下し、シタグリプチンにより増加 https://t.co/z41LQspULA
RT @DanielJDrucker: More evidence for the IL-6 GLP-1 axis in humans @DiabetologiaJnl https://t.co/BKjjXDS1qz
More evidence for the IL-6 GLP-1 axis in humans @DiabetologiaJnl https://t.co/BKjjXDS1qz